Developer docs
API playgroundTry for free, no card

Search company profiles

DCVC

Full company profile

uuid00005sk

Namestring
DCVC
Legal namestring
DCVC Management Co, LLC
Websiteurl
dcvc.com
Company typeenum
Private
Founded yearint
2011
Descriptiontext

DCVC is a Palo Alto-based deep tech venture capital firm founded in 2011 by Matthew Ocko and Zachary Bogue as Data Collective, rebranding to DCVC while retaining Data Collective as a registered trademark. The firm invests across approximately $4 billion in assets under management spanning 13 funds, including six flagship DCVC funds and three DCVC Bio life sciences funds (the latter established in 2018 and co-led by Dr. John Hamer and Dr. Kiersten Stead). DCVC backs founders applying AI, exa-scale computing, and deep domain expertise to high-stakes problems in climate, energy, life sciences, defense, security, space, agriculture, advanced manufacturing, and quantum computing. The firm employs roughly 45 people across Palo Alto and San Francisco and explicitly emphasizes a scientist-led partnership structure ("more published scientists than MBAs") to underwrite capital-intensive hardware and biotech bets that competitor VCs decline.

The firm's revenue model combines recurring management fees on committed capital across its fund vehicles (with the most recent vintage closing at $700M+ in flagship funds and $400M for DCVC Bio III in 2024) and lumpy, performance-based carried interest tied to portfolio exits such as the May 2026 Fervo Energy IPO (Nasdaq: FRVO) and prior exits including Rocket Lab, SentinelOne, Confluent, AbCellera, Elastic, Databricks, Planet, Zymergen, Ginkgo Bioworks, and Oklo. Distribution of capital occurs via direct LP fundraising and a co-investor syndicate that includes Founders Fund, Andreessen Horowitz, Playground Global, Activate Capital, Munich Re Ventures, and Breakthrough Energy Ventures, while deal sourcing relies on partner-led founder engagement reinforced by an owned editorial platform (annual Deep Tech Opportunities Report, Climate Impact Report, quarterly newsletter, 47 archived press releases).

The 200+ company portfolio is organized across content verticals — AI/Compute/Quantum, Computational Bio & Chem, Cybersecurity/Defense, Energy & Climate, Industrial Transformation, Next-Gen Agriculture, Space, TechBio, and TechMed — and ranges from seed through Series D+. Notable positions span Fervo Energy (geothermal, IPO'd May 2026), Atom Computing and Quantum Motion (quantum), Mythic and Unconventional AI (AI compute), Agility Robotics (humanoid robotics, planning SPAC at ~$2.5B), Proxima (AI-native therapeutics), Halter (precision agriculture), ElectronX (energy derivatives), Radiant (nuclear microreactors), Slip Robotics (automated truck loading), and ZwitterCo (membrane technology), among others.

Short descriptiontext

DCVC is a Palo Alto-based deep tech venture capital firm managing approximately $4 billion across 13 funds, backing founders applying AI and computational science to climate, life sciences, quantum, defense, and industrial challenges. The firm employs ~45 people and has invested in 200+ companies.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersPalo Alto, United States
HQ citystring
Palo Alto
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices2 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
deep tech venture capital, venture capital funds, life sciences investing, climate tech investment, quantum computing investing
Industry2 codes
1Corporate Venture Capital (CVC)
CodeFSANAAAFPrimaryYes
2Corporate Deep Tech / R&D Commercialization CVC
CodeFSANAHALPrimaryNo
NAICS code2 codes
  • Portfolio Management and Investment Advice523940
  • Funds, Trusts, and Other Financial Vehicles525
SIC code1 code
  • Miscellaneous Business Credit Institution6159
Product category
Venture Capital
Social media profiles2 records
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model3 records
1Fund management fees
TypeSubscription Recurring
Description

Recurring management fees on the firm's $4B AUM, generated across 13 funds to date (including six flagship DCVC funds and three DCVC Bio funds)

dcvc.com
2Carried interest on fund returns
TypeManaged Services
Description

Performance-based carried interest earned when portfolio companies exit via IPO or acquisition (e.g., recent IPOs include Fervo Energy on Nasdaq: FRVO; prior exits include Rocket Lab, SentinelOne, Confluent, AbCellera, Elastic, Amplitude, Desktop Metal, Ginkgo Bioworks, Oklo, Evolv Technology, Planet, Zymergen, Databricks, Embark, AgileAI via acquisitions)

dcvc.com
3Co-investment and syndication economics
TypeTransaction Fee
Description

DCVC frequently co-leads and participates in rounds alongside co-investors (e.g., Kembara, Playground Global, Founders Fund, a16z, B Capital, Activate Capital, Munich Re Ventures, British Business Bank, Breakthrough Energy Ventures), sharing economics from rounds led by the firm or in which it participates

dcvc.com
Marketing channels8 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels5 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Operations, Marketing or Sales, Technology or R&D, Infrastructure
Pricing details1 tier
1Fund commitments to limited partners (LP allocations) — terms not publicly disclosed
ModelOtherBilling cadenceMulti-year contract
Notes

Standard VC fund structure with management fees and carried interest; specific fee percentages, hurdle rates, and minimum LP commitments are not disclosed publicly

dcvc.com
GTM typeB2B
B2B
Offering typeServices
Services
Core offering1 text field

DCVC is a deep tech venture capital firm that invests from seed through growth stage using a scientist-led diligence approach across AI, compute, quantum, climate, energy, life sciences, defense, space, and industrial sectors. The firm manages approximately $4 billion in assets under management across 13 funds, including six flagship DCVC funds and three DCVC Bio life-sciences funds, deploying patient capital and operating-partner support to founders addressing trillion-dollar real-world problems.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 4 values shown
  • 2024 Deep Tech Opportunities Report and Climate Impact Report published; over $700M in new DCVC Climate funds closed in 2024
+3 more records
Product and service3 records
1DCVC Flagship Deep Tech Funds
CategoryCore platform / venture capital fund franchise
Description

DCVC's six flagship venture capital funds that back companies using AI and deep tech to tackle trillion-dollar real-world problems across climate, energy, defense, security, compute, and industrial sectors. Managed by Managing Partners Matt Ocko and Zachary Bogue.

2DCVC Bio (Life Sciences Funds)
CategorySub-fund / vertical (life sciences)
Description

DCVC's life-sciences venture capital franchise (est. 2018) comprising three funds that back companies applying AI, computational biology, and deep biotech to human health, agriculture, and synthetic biology. Co-founded and led by Dr. John Hamer, Dr. Kiersten Stead, Matt Ocko, and Zachary Bogue.

3DCVC Bio III Fund
CategoryVenture capital fund vehicle (life sciences)
Description

Third and largest life-sciences fund under the DCVC Bio franchise, closed at $400 million in September 2024 for investing in DCVC Bio portfolio companies in human health, agriculture, and synthetic biology.

Scale indicator9 records

Each record includes

Type, Value, Description, Source

Partnership6 partners
Strategic tierFlagshipTypeStrategic or Co-development PartnerAnnounced on2026-05-21
Description

DCVC explicitly highlighted a $2B U.S. Department of Commerce investment across nine quantum companies, materially involving four DCVC portfolio companies: Atom Computing ($100M equity stake), Quantum Motion (via $375M allocation to GlobalFoundries), Rigetti Computing ($100M), and Q-CTRL (with IBM, which received $1B). DCVC engages directly with federal quantum policy through Operating Partner Dr. Prineha Narang.

2Government of Saudi Arabia (Ministry of Industry and Mineral Resources)
Strategic tierFlagshipTypeStrategic or Co-development PartnerAnnounced on2026-05-14
Description

DCVC engaged in a ministerial meeting at the Milken Institute Global Conference 2026 with Tidal Metals and the U.S. side, targeting cooperation with Saudi Arabia in mineral exploration and processing technology as part of the Kingdom's Vision 2030 strategy.

discoveryalert.com.au
Strategic tierFlagshipTypeGTM or Marketing PartnerAnnounced on2026-05-13
Description

DCVC partner Zachary Bogue and Dr. Rachel Slaybaugh joined Fervo Energy co-founders Tim Latimer and Jack Norbeck on the podium to ring the Nasdaq opening bell in celebration of Fervo's IPO under ticker FRVO. Fervo was first invested by DCVC in 2022 and represents one of the firm's flagship climate tech exits.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2026-05-07
Description

GlobalFoundries is the foundry manufacturing partner for DCVC portfolio company Quantum Motion, enabling production of silicon-spin-qubit quantum chips using standard CMOS processes; the U.S. Department of Commerce allocated $375M to GlobalFoundries to scale this capacity.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2025-12-17
Description

Microsoft is partnering with DCVC portfolio company Atom Computing to install the world's first commercial quantum computer with logical qubits — a significant ecosystem relationship that anchors the Atom Computing roadmap and reinforces DCVC's quantum portfolio thesis.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2025-05-06
Description

Gates Foundation participated in Kanvas Biosciences' $48M Series A (co-led by DCVC and Lions Capital) and is partnering with Kanvas on a synthetic microbiome product for maternal environmental enteric dysfunction, a condition affecting ~150M people worldwide primarily in Southern Asia and Sub-Saharan Africa.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers5 records
TypeDirect peer
TypeDirect peer
Description

Lux Capital is a deep tech venture capital firm investing across AI, compute, quantum, space, biology, and advanced manufacturing, with a scientist-led partnership model nearly identical to DCVC. Both firms compete directly for the same founder pool and co-invest alongside each other in quantum and life sciences rounds.

TypeDirect peer
Description

Khosla Ventures is a large deep tech and climate venture firm with $15B+ AUM and a comparable science-led thesis spanning clean energy, biotech, AI, and frontier tech. It is one of the most direct competitors for DCVC's deep tech deal flow and is co-listed alongside DCVC in quantum investor rankings.

TypeBroad incumbent
Description

Andreessen Horowitz operates a $35B+ multi-stage venture franchise spanning bio/health, crypto, infrastructure, and increasingly deep tech. While not a pure-play deep tech firm, a16z increasingly competes for the same quantum, robotics, and defense founders (e.g., co-led Chariot Defense with DCVC).

TypeDirect peer
Description

Breakthrough Energy Ventures is a $2B+ climate-focused venture fund backed by Bill Gates that invests in companies addressing climate change across energy, agriculture, transportation, and industrial decarbonization. It is a co-investor with DCVC in companies such as Fourth Power and shares the climate deep tech mandate.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat6 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment6 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature2 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles14 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries1 record

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment597 records

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

DCVC

Venture Capitaldcvc.com

DCVC is a Palo Alto-based deep tech venture capital firm managing approximately $4 billion across 13 funds, backing founders applying AI and computational science to climate, life sciences, quantum, defense, and industrial challenges. The firm employs ~45 people and has invested in 200+ companies.

What DCVC does

DCVC is a Palo Alto-based deep tech venture capital firm founded in 2011 by Matthew Ocko and Zachary Bogue as Data Collective, rebranding to DCVC while retaining Data Collective as a registered trademark. The firm invests across approximately $4 billion in assets under management spanning 13 funds, including six flagship DCVC funds and three DCVC Bio life sciences funds (the latter established in 2018 and co-led by Dr. John Hamer and Dr. Kiersten Stead). DCVC backs founders applying AI, exa-scale computing, and deep domain expertise to high-stakes problems in climate, energy, life sciences, defense, security, space, agriculture, advanced manufacturing, and quantum computing. The firm employs roughly 45 people across Palo Alto and San Francisco and explicitly emphasizes a scientist-led partnership structure ("more published scientists than MBAs") to underwrite capital-intensive hardware and biotech bets that competitor VCs decline.

The firm's revenue model combines recurring management fees on committed capital across its fund vehicles (with the most recent vintage closing at $700M+ in flagship funds and $400M for DCVC Bio III in 2024) and lumpy, performance-based carried interest tied to portfolio exits such as the May 2026 Fervo Energy IPO (Nasdaq: FRVO) and prior exits including Rocket Lab, SentinelOne, Confluent, AbCellera, Elastic, Databricks, Planet, Zymergen, Ginkgo Bioworks, and Oklo. Distribution of capital occurs via direct LP fundraising and a co-investor syndicate that includes Founders Fund, Andreessen Horowitz, Playground Global, Activate Capital, Munich Re Ventures, and Breakthrough Energy Ventures, while deal sourcing relies on partner-led founder engagement reinforced by an owned editorial platform (annual Deep Tech Opportunities Report, Climate Impact Report, quarterly newsletter, 47 archived press releases).

The 200+ company portfolio is organized across content verticals — AI/Compute/Quantum, Computational Bio & Chem, Cybersecurity/Defense, Energy & Climate, Industrial Transformation, Next-Gen Agriculture, Space, TechBio, and TechMed — and ranges from seed through Series D+. Notable positions span Fervo Energy (geothermal, IPO'd May 2026), Atom Computing and Quantum Motion (quantum), Mythic and Unconventional AI (AI compute), Agility Robotics (humanoid robotics, planning SPAC at ~$2.5B), Proxima (AI-native therapeutics), Halter (precision agriculture), ElectronX (energy derivatives), Radiant (nuclear microreactors), Slip Robotics (automated truck loading), and ZwitterCo (membrane technology), among others.

DCVC firmographics

Firmographics
Name
DCVC
Legal name
DCVC Management Co, LLC
Website
https://dcvc.com
Company type
Private
Founded year
2011
Operating status
Operating
Headcount range
11–50 employees
Short description
DCVC is a Palo Alto-based deep tech venture capital firm managing approximately $4 billion across 13 funds, backing founders applying AI and computational science to climate, life sciences, quantum, defense, and industrial challenges. The firm employs ~45 people and has invested in 200+ companies.
Ownership category
akta.pro rank

DCVC industry classification

Industry
Product category
Venture Capital
NAICS
Portfolio Management and Investment Advice (523940), Funds, Trusts, and Other Financial Vehicles (525)
SIC
Miscellaneous Business Credit Institution (6159)
akta.pro primary industry
Corporate Venture Capital (CVC) (FSANAAAF)
akta.pro secondary industry
Corporate Deep Tech / R&D Commercialization CVC (FSANAHAL)

Keywords

  • Deep tech venture capital
  • Venture capital funds
  • Life sciences investing
  • Climate tech investment
  • Quantum computing investing

Where DCVC is headquartered

Location

Headquarters

HQ city
Palo Alto
HQ country
United States
HQ region
North America

Offices2 records

Markets served

DCVC business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Operations, Marketing or Sales, Technology or R&D, Infrastructure

Revenue model

  1. Fund management fees: Recurring management fees on the firm's $4B AUM, generated across 13 funds to date (including six flagship DCVC funds and three DCVC Bio funds)
  2. Carried interest on fund returns: Performance-based carried interest earned when portfolio companies exit via IPO or acquisition (e.g., recent IPOs include Fervo Energy on Nasdaq: FRVO; prior exits include Rocket Lab, SentinelOne, Confluent, AbCellera, Elastic, Amplitude, Desktop Metal, Ginkgo Bioworks, Oklo, Evolv Technology, Planet, Zymergen, Databricks, Embark, AgileAI via acquisitions)
  3. Co-investment and syndication economics: DCVC frequently co-leads and participates in rounds alongside co-investors (e.g., Kembara, Playground Global, Founders Fund, a16z, B Capital, Activate Capital, Munich Re Ventures, British Business Bank, Breakthrough Energy Ventures), sharing economics from rounds led by the firm or in which it participates

Pricing tiers

ModelBillingPrice
OtherMulti-year contractFund commitments to limited partners (LP allocations) — terms not publicly disclosed

Go-to-market motion1 record

Distribution channels5 records

Marketing channels8 records

DCVC product offering

Product offering

Core offering

DCVC is a deep tech venture capital firm that invests from seed through growth stage using a scientist-led diligence approach across AI, compute, quantum, climate, energy, life sciences, defense, space, and industrial sectors. The firm manages approximately $4 billion in assets under management across 13 funds, including six flagship DCVC funds and three DCVC Bio life-sciences funds, deploying patient capital and operating-partner support to founders addressing trillion-dollar real-world problems.

Differentiator

Problem solved

Functional benefit

Products and services

  • DCVC Flagship Deep Tech Funds DCVC's six flagship venture capital funds that back companies using AI and deep tech to tackle trillion-dollar real-world problems across climate, energy, defense, security, compute, and industrial sectors. Managed by Managing Partners Matt Ocko and Zachary Bogue.
  • DCVC Bio (Life Sciences Funds) DCVC's life-sciences venture capital franchise (est. 2018) comprising three funds that back companies applying AI, computational biology, and deep biotech to human health, agriculture, and synthetic biology. Co-founded and led by Dr. John Hamer, Dr. Kiersten Stead, Matt Ocko, and Zachary Bogue.
  • DCVC Bio III Fund Third and largest life-sciences fund under the DCVC Bio franchise, closed at $400 million in September 2024 for investing in DCVC Bio portfolio companies in human health, agriculture, and synthetic biology.

Quantifiable outcome

  • 2024 Deep Tech Opportunities Report and Climate Impact Report published; over $700M in new DCVC Climate funds closed in 2024
  • +3 more outcomes

Companies that use DCVC

Customer profile

Segments6 records

Ideal customer profiles2 records

DCVC technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature2 records

DCVC partnerships and signals

Strategic signal

Partnerships

Six partnerships are on record, tiered flagship and core.

  • U.S. Department of Commerce (CHIPS R&D Office)flagshipStrategic or Co-development Partner · 21 May 2026DCVC explicitly highlighted a $2B U.S. Department of Commerce investment across nine quantum companies, materially involving four DCVC portfolio companies: Atom Computing ($100M equity stake), Quantum Motion (via $375M allocation to GlobalFoundries), Rigetti Computing ($100M), and Q-CTRL (with IBM, which received $1B). DCVC engages directly with federal quantum policy through Operating Partner Dr. Prineha Narang.
  • Government of Saudi Arabia (Ministry of Industry and Mineral Resources)flagshipStrategic or Co-development Partner · 14 May 2026DCVC engaged in a ministerial meeting at the Milken Institute Global Conference 2026 with Tidal Metals and the U.S. side, targeting cooperation with Saudi Arabia in mineral exploration and processing technology as part of the Kingdom's Vision 2030 strategy.
  • Nasdaq Stock MarketflagshipGTM or Marketing Partner · 13 May 2026DCVC partner Zachary Bogue and Dr. Rachel Slaybaugh joined Fervo Energy co-founders Tim Latimer and Jack Norbeck on the podium to ring the Nasdaq opening bell in celebration of Fervo's IPO under ticker FRVO. Fervo was first invested by DCVC in 2022 and represents one of the firm's flagship climate tech exits.
  • GlobalFoundries (via Quantum Motion)coreStrategic or Co-development Partner · 7 May 2026GlobalFoundries is the foundry manufacturing partner for DCVC portfolio company Quantum Motion, enabling production of silicon-spin-qubit quantum chips using standard CMOS processes; the U.S. Department of Commerce allocated $375M to GlobalFoundries to scale this capacity.
  • Microsoft (via Atom Computing)coreStrategic or Co-development Partner · 17 December 2025Microsoft is partnering with DCVC portfolio company Atom Computing to install the world's first commercial quantum computer with logical qubits — a significant ecosystem relationship that anchors the Atom Computing roadmap and reinforces DCVC's quantum portfolio thesis.
  • Gates FoundationcoreStrategic or Co-development Partner · 6 May 2025Gates Foundation participated in Kanvas Biosciences' $48M Series A (co-led by DCVC and Lions Capital) and is partnering with Kanvas on a synthetic microbiome product for maternal environmental enteric dysfunction, a condition affecting ~150M people worldwide primarily in Southern Asia and Sub-Saharan Africa.

Scale indicators9 records

Recent moves6 records

Expansion highlights6 records

DCVC competitors and assessment

Company assessment

Direct peers

  • Playground Global:
  • Lux Capital: Lux Capital is a deep tech venture capital firm investing across AI, compute, quantum, space, biology, and advanced manufacturing, with a scientist-led partnership model nearly identical to DCVC. Both firms compete directly for the same founder pool and co-invest alongside each other in quantum and life sciences rounds.
  • Khosla Ventures: Khosla Ventures is a large deep tech and climate venture firm with $15B+ AUM and a comparable science-led thesis spanning clean energy, biotech, AI, and frontier tech. It is one of the most direct competitors for DCVC's deep tech deal flow and is co-listed alongside DCVC in quantum investor rankings.
  • Breakthrough Energy Ventures: Breakthrough Energy Ventures is a $2B+ climate-focused venture fund backed by Bill Gates that invests in companies addressing climate change across energy, agriculture, transportation, and industrial decarbonization. It is a co-investor with DCVC in companies such as Fourth Power and shares the climate deep tech mandate.

Broad incumbents

  • Andreessen Horowitz (a16z): Andreessen Horowitz operates a $35B+ multi-stage venture franchise spanning bio/health, crypto, infrastructure, and increasingly deep tech. While not a pure-play deep tech firm, a16z increasingly competes for the same quantum, robotics, and defense founders (e.g., co-led Chariot Defense with DCVC).

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks6 records

Key highlights7 records

Customer concentration

DCVC social profiles

Digital presence

DCVC financial estimates

Financial estimate

Revenue estimate

Valuation estimate

DCVC leadership team

Management profile

Number of profiles

Profiles14 records

DCVC subsidiaries and ownership

Company hierarchy

Subsidiaries1 record

DCVC funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

DCVC M&A and investment

M&A and investment

M&A

Investments597 records

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about DCVC

What does DCVC do?

DCVC is a deep tech venture capital firm that invests from seed through growth stage using a scientist-led diligence approach across AI, compute, quantum, climate, energy, life sciences, defense, space, and industrial sectors. The firm manages approximately $4 billion in assets under management across 13 funds, including six flagship DCVC funds and three DCVC Bio life-sciences funds, deploying patient capital and operating-partner support to founders addressing trillion-dollar real-world problems.

Is DCVC a public or private company?

DCVC is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was DCVC founded?

DCVC was founded in 2011. It employs 11 to 50 people.

Where is DCVC based?

DCVC is headquartered in Palo Alto, United States, in the North America region.

How does DCVC make money?

Three revenue lines are on record. Fund management fees are the primary driver. The others are carried interest on fund returns and co-investment and syndication economics.

Who are DCVC's main competitors?

Direct peers on record are Playground Global, Lux Capital, Khosla Ventures and Breakthrough Energy Ventures. Andreessen Horowitz (a16z) is listed as a broad incumbent.

Does DCVC have an API?

No public API is recorded for DCVC.

What industry is DCVC in?

DCVC's product category is Venture Capital. Its primary akta.pro industry code is FSANAAAF, Corporate Venture Capital (CVC), with a secondary code of FSANAHAL, Corporate Deep Tech / R&D Commercialization CVC. Its NAICS code is 523940 and its SIC code is 6159.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
DoNewsAlmeida 推出 AI 模型 Jev,不生成文本、输出免费- DoNewsTypeSafe AI launched Jev, a System One model that outputs structured decisions without generating text. The company raised $40 million in seed funding led by DCVC. Jev claims 20-200x faster speed and 40-400x lower cost than large language models, with output tokens free.Panewslab不写文本只做决策:Jev模型为何在24小时内覆盖Vercel 13%付费团队?Jev is a model that makes structured judgments without generating text, and it has covered 13% of Vercel's paid teams within 24 hours. Its long-term performance remains uncertain due to undisclosed architecture and lack of production failure data, but community replication projects are following up.PlatumAn AI model that assigns probabilities to each option instead of stating the answer.TypeSafe AI released Jev, a model that assigns probabilities to predefined options instead of generating text, on September 15. The company announced a $40 million seed round led by DCVC, and claims Jev is 193.6 times faster and 444.6 times cheaper than top LLMs. The model is in early access with API access granted to waiting-list developers.36krViral Global AI Star Jev: The Hottest New Trending AI That Never Speaks — Complete Guide on How to Use ItTypeSafe AI launched Jev, a non-speech AI model, on September 15 with a $40 million seed round. Jev outputs typed choices, scores, or probabilities, with latency 70-500ms and input cost $0.042 per million tokens. The company plans more model versions for different scenarios.SalesTech StarTypeSafe AI Emerges From Stealth With $40M in Funding With New Model for Composable AITypeSafe AI emerged from stealth with $40 million in seed funding led by DCVC. Its Jev model delivers frontier-level intelligence at under 100 milliseconds latency, up to 100 times faster and cheaper than other frontier models. The company aims to make composable AI a standard building block for software.Venture Capital Access OnlineShennon Biotechnologies Raises $12M in Financing, Appoints Cyril Konto, M.D., as Chief Executive Officer and Unveils Precision Immunotherapy PipelineShennon Biotechnologies raised $12M in financing from multiple investors, bringing its total to $25M. The company appointed Cyril Konto as CEO, with founder Li Sun transitioning to President and CTO. The funds will advance three T-cell engager programs for small cell lung cancer, ovarian cancer, and hepatocellular carcinoma toward clinical development.Pulse 2.0Shennon Biotechnologies Raises $12 Million, Names Cyril Konto As CEO, And Unveils Precision Immunotherapy PipelineShennon Biotechnologies raised $12 million in financing and appointed Cyril Konto as CEO, bringing total capital to $25 million. The funds will advance three T-cell engager programs for small-cell lung cancer, ovarian cancer, and hepatocellular carcinoma. The company plans to advance a development candidate toward an IND filing within two years.BioSpaceShennon Biotechnologies Raises $12M in Financing, Appoints Cyril Konto, M.D., as Chief Executive Officer and Unveils Precision Immunotherapy PipelineShennon Biotechnologies raised $12M in financing and appointed Cyril Konto as CEO, with founder Li Sun moving to President and CTO. The company has raised $25M to date and is advancing three T-cell engager programs for small cell lung cancer, ovarian cancer, and hepatocellular carcinoma. It plans to advance a development candidate toward IND filing within two years.FinSMEsShennon Biotechnologies Raises $12M in FundingShennon Biotechnologies raised $12M in funding, bringing its total to $25M. The San Francisco-based biotech will use the funds to develop its integrated technology platform and advance its oncology pipeline, which includes three T-cell engager programs for small cell lung cancer, ovarian cancer, and hepatocellular carcinoma.Business Wire BlogShennon Biotechnologies Raises $12M in Financing, Appoints Cyril Konto, M.D., as Chief Executive Officer and Unveils Precision Immunotherapy PipelineShennon Biotechnologies raised $12M in financing and appointed Cyril Konto as CEO, with founder Li Sun moving to president and CTO. The company has raised $25M to date and is advancing three T-cell engager programs for small cell lung cancer, ovarian cancer, and hepatocellular carcinoma. It plans to advance a development candidate toward IND filing and Phase 1 within two years.